Who this is for
Heads of medical affairs and medical directors
You need to know what changed this week, what it means for the medical plan, and whether your teams are duplicating each other's work. MedIntel gives you the first two in a summary you can read in ten minutes, and takes care of the third.
Medical strategy and launch teams
Launch plans depend on knowing exactly where the evidence stands, where the gaps are and what the competition will present next. That picture stays current here rather than in a deck that was right in March.
Field medical leadership
Your MSLs cover more experts than they can track by hand. With profiles that stay current and a brief before each meeting, the team spends its preparation time on judgment rather than searching.
Medical information, publications and HEOR
Each of these teams draws on the same body of evidence for a different purpose. They share one source, and each gets a workspace organized around the questions it answers every week.
What changes for the team
How the work tends to look today, and how it looks once MedIntel is in place.
How MedIntel helps
A shared picture of the therapy area
Publications, registered trials, congress presentations, regulatory decisions, guidelines and health technology assessments for your products and competitors sit in one place, searchable together. When a new medical science liaison joins, or a medical director picks up a second indication, the picture is already there. Saved searches stay saved, so the team stops rebuilding the same landscape every quarter.
Knowing what changed without going to look
Put the products, trials, experts and competitors that matter on a watchlist. When one of them moves, the people responsible are told that day. Everything else is gathered into a weekly digest written as a briefing: what happened, why it matters, and who should look at it. Most medical leaders read it on Monday morning and forward it unchanged.
A workspace for each medical team
Field medical, medical information, publications, medical strategy, HEOR, clinical development and drug safety ask different questions of the same evidence. Each gets its own view, with the searches, alerts and summaries that suit its work. The evidence underneath stays shared, which is what keeps five teams from producing five versions of the same answer.
Briefings and drafts you can check
When someone needs a briefing on a competitor's new data, a literature summary or a first draft of a response, MedIntel writes it. Every sentence links to the record it came from, and nothing goes anywhere until a person on your team approves it. The first draft arrives in minutes. The review your organization requires still happens.
Defensible by design
Medical work is reviewed, audited and occasionally questioned. Records show where they came from and when. Safety-relevant findings can be routed to drug safety in one click, with the hand-off logged. When someone asks how a conclusion was reached six months ago, the trail is there.
An example
A competitor presents phase 3 data at a congress
On Thursday afternoon a competitor presents its phase 3 results in a late-breaking session. Their product is on your watchlist, so within the hour the medical strategy lead, the medical director and the MSLs who cover the study's investigators are told.
By Friday morning there is a draft briefing on the medical director's desk. It sets out what was presented, how it compares with your own data on the endpoints that matter, and which questions experts are likely to raise. Each statement links back to the abstract or the record it came from, so the review takes twenty minutes rather than a day.
Once it is approved, the field team has it before their Monday meetings. Medical information has it too, because the inquiries will start next week. Nobody had to forward an email or ask whether someone else was already working on it.
Common questions
If yours isn't here, ask us directly.
What is a medical affairs intelligence platform?
It is a shared working environment where a medical organization keeps up with the science, the experts, the competition and the regulatory picture for its products. The routine monitoring happens in the background, and each team sees the results in the form its own work needs. MedIntel is built for Medical Affairs and Clinical teams in pharmaceutical and biotech companies.
How is it different from the search tools our team already uses?
A search tool answers the question you ask it. MedIntel keeps watching after you have stopped asking, shares what it finds across the function, and connects a new finding to the trial, the expert and the competitor it relates to. Most teams keep their search tools for detailed research and use MedIntel to stay current.
Which teams in medical affairs use it?
Medical leadership, medical strategy, field medical, medical information, publications and HEOR most often, along with clinical development and drug safety. Each has its own workspace, and they all work from the same underlying picture.
Does it replace our CRM or our medical information system?
No. It sits alongside them. MedIntel is where the team goes to understand what is happening in the therapy area. Records that belong in your CRM or your medical information system stay there.
How long does it take to get started?
A team is usually working in it within a few weeks. Most of that time goes into agreeing which products, competitors, experts and topics to follow and who should receive what. There is no data migration.
How do you keep AI-drafted content appropriate for a medical organization?
Every draft can be traced back to the evidence it summarizes, and nothing is shared until a person on your team has reviewed and approved it. You get the speed of a first draft without giving up the review your organization requires.
Further reading
Glossary: Evidence gap, Health technology assessment, Medical information, Medical intelligence, Medical science liaison, Share of voice